Effect of mirabegron in patients with myasthenia gravis disease and overactive bladder symptoms

Effect of mirabegron in patients with myasthenia gravis disease and overactive bladder symptoms

Bibliographic Details
Main Authors:	M.G. Çulha, O. Akan, E. Abay, F. Altunrende, A. Otunctemur
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320327476

Similar Items

Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022-09-01)

Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021-04-01)

Patient utilization survey of mirabegron prescribed for overactive bladder
by: Päivi Rahkola-Soisalo, et al.
Published: (2019-03-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
by: Shaw C, et al.
Published: (2023-01-01)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017-02-01)

Re: Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder
by: Sinharib Çitgez
Published: (2016-12-01)

Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
by: Makhani A, et al.
Published: (2020-04-01)

The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
by: Marilena Gubbiotti, et al.
Published: (2019-01-01)

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022-05-01)

Impact of Mirabegron Administration on the Blood Pressure and Pulse Rate in Patients with Overactive Bladder
by: Hidenori Ito, et al.
Published: (2022-06-01)

Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)
by: Hiroshi Nakagomi, et al.
Published: (2022-03-01)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
by: Luisa Gracio Ferreira Sartori, et al.
Published: (2023-08-01)

Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
by: Ömer Acar, et al.
Published: (2019-06-01)

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013-04-01)

Mirabegron: A first-in-class beta-3 agonist for overactive bladder
by: Suruchi Aditya, et al.
Published: (2015-01-01)

Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study
by: Marilena Gubbiotti, et al.
Published: (2019-05-01)

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence
by: Mete Özkidik, et al.

Mirabegron: a review of recent data and its prospects in the management of overactive bladder
by: Emilio Sacco, et al.
Published: (2012-12-01)

Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients
by: Yuh-Chen Kuo, et al.
Published: (2023-01-01)

Mirabegron for Overactive Bladder: A Novel, First-in-Class β3- Agonist Therapy
by: Mohammed Imran, et al.
Published: (2013-09-01)

Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder
by: Jingjun Wang, et al.
Published: (2023-05-01)

Unraveling the impact of Lactobacillus spp. and other urinary microorganisms on the efficacy of mirabegron in female patients with overactive bladder
by: Zhipeng Zhou, et al.
Published: (2022-11-01)

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study
by: Se Yun Kwon, et al.
Published: (2020-07-01)

Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
by: Lee RT, et al.
Published: (2013-10-01)

Efficacy and tolerability of mirabegron compared with solifenacin for children with idiopathic overactive bladder: A preliminary study
by: Seong Cheol Kim, et al.
Published: (2021-05-01)

The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study
by: A. Zachariou, et al.
Published: (2018-06-01)

Factors associated with antimuscarinic drug persistence and increasing drug persistence after switching to mirabegron for overactive bladder patients
by: Chung-Cheng Wang, et al.
Published: (2019-01-01)

Mirabegron add-on therapy to tamsulosin in men with overactive bladder: Post-hoc analyses of efficacy from the MATCH study
by: H. Kakizaki, et al.
Published: (2020-07-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
by: Jameel Nazir, et al.
Published: (2018-09-01)

Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study
by: Qing-lai Tang, et al.
Published: (2022-11-01)

Lower Urinary Tract Symptoms in Myasthenia Gravis
by: Fuyuki Tateno, et al.
Published: (2021-07-01)

Older patients with idiopathic, wet overactive bladder and multiple comorbidities: May mirabegron represent a first choice pharmacological agent?
by: M. Gubbiotti, et al.
Published: (2020-07-01)

Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study
by: Ping Liang, et al.
Published: (2024-04-01)

Myasthenia gravis
by: Vincent, A
Published: (2007)

Myasthenia gravis.
by: Vincent, A, et al.
Published: (2004)

Myasthenia gravis.
by: Vincent, A, et al.
Published: (2002)

Myasthenia gravis.
by: Vincent, A, et al.
Published: (2001)